Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-12

FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved the supplemental application for methylphenidate hydrochloride from Actavis Pharma, Inc., resulting in an approved supplemental change to the produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)